Skip to main content
. 2021 Jan 15;22(2):818. doi: 10.3390/ijms22020818

Figure 3.

Figure 3

The hepatic expression of lipogenic enzymes and inflammatory markers in ApoE(-/-) mice after five weeks of empagliflozin/vehicle oral administration. (A). The mRNA levels of Fasn, Screbp-1 and Pck-1 were significantly reduced in the Empa group as compared to the Control group. (B) Empagliflozin oral administration for five weeks resulted in significant reduction in Mcp-1 and F4/80 mRNA levels. Data are shown as the mean ± SEM (*: p < 0.05).